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N eonatal eosinophilia,  which is defined as an eosinophil count exceeding 0.7 × 109/L,  is esti-
mated to occur in 14-76% of preterm neonates [1-4].  
Eosinophilia in preterm infants is considered a transient 
condition after birth because in most cases,  the eosino-
phil count returns to normal by the time of discharge 
from the neonatal intensive care unit (NICU).  However,  
considerable morbidities are associated with eosino-
philia in preterm infants,  and the morbidities increase 
with prematurity.  Chronic lung disease [5-7],  paren-
teral nutrition [4],  infection [8 , 9],  and blood transfu-
sion [1] are correlated with eosinophilia; however,  the 
underlying pathophysiology of eosinophilia in preterm 
infants has not been fully elucidated.  Elevated eosinophil 
counts in peripheral blood may reflect adrenal insuffi-
ciency [10].  Glucocorticoids,  the most effective therapy 
for eosinophilia,  suppress cytokines that induce eosin-
ophil production and shorten the cytokines’ lifespans.
Late-onset circulatory collapse (LCC) is a disorder 
that occurs suddenly,  manifests as hypotension and 
oliguria,  and results in shock among preterm infants 
who survive the acute stage after birth [11 , 12].  The 
most severe complication of LCC is periventricular leu-
komalacia.  The synthesis of progesterone from preg-
nenolone is catalyzed by 3β-hydroxy-steroid dehydro-
genase (3β-HSD),  which has limited activity before 
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Late-onset circulatory collapse (LCC) in preterm infants is presumably caused by relative adrenal insufficiency.  
Because eosinophilia is known to be associated with adrenal insufficiency,  we attempted to clarify the relation-
ship between eosinophilia and LCC in preterm infants.  We divided the cases of the infants (born at < 28 weeks’ 
gestation) admitted to our neonatal intensive care unit in 2008-2010 into 2 groups: those diagnosed with LCC 
that received glucocorticoids (LCC group),  and those who did not receive glucocorticoids (control group).  We 
compared eosinophil counts between the 2 groups and between before and after glucocorticoid treatment in the 
LCC group.  A total of 28 infants were examined: LCC group (n = 12); control group (n = 16).  The peak eosin-
ophil counts of the LCC group were significantly higher than those of the control group (median:  
1.392 × 109/L vs.  1.033 × 109/L,  respectively; p= 0.02).  Additionally,  in the LCC group,  the eosinophil counts 
declined significantly after glucocorticoid treatment (0.877 × 109/L vs.  0.271 × 109/L,  p= 0.003).  Eosinophil 
counts in the LCC group were significantly higher than in the control group and decreased rapidly after gluco-
corticoid treatment.  These results indicate that eosinophilia may be a factor associated with LCC caused by 
adrenal insufficiency.
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35 weeks of post-conceptual age.  Fetal cortisol synthe-
sis takes place in the placenta [11 , 13].  The lack of pro-
gesterone from the placenta after birth causes relative 
adrenal insufficiency that induces LCC in extremely 
preterm infants [14].  LCC includes systemic vasodila-
tion,  and hydrocortisone is reported to be a highly 
effective treatment [15].
We hypothesized that adrenal insufficiency in 
extremely preterm infants would induce elevated eosin-
ophil counts.  However,  there are no reports on the 
eosinophil counts of infants with LCC.  In the present 
study,  we aimed to elucidate the relationship between 
eosinophilia and LCC in preterm infants.
Subjects and Methods
This was a single-center retrospective study.  Data 
were collected from medical records of infants born 
before 28 weeks’ gestation and hospitalized in the NICU 
of Tokyo Women’s Medical University Hospital during 
the period from February 2008 to October 2010.  This 
study was approved by the Internal Review Board of 
Tokyo Women’s Medical University.  Written informed 
consent was obtained from the parents of the patients.  
Infants with congenital anomalies,  chromosomal 
abnormalities,  or severe intraventricular hemorrhage 
(grade III or IV) were excluded.  Intraventricular hem-
orrhage was diagnosed by intracranial echography and 
categorized as grade I-IV based on diagnostic criteria 
[16].  Respiratory distress syndromes were diagnosed by 
stable microbubble rating and chest X-ray before sur-
factant administration.  Chorioamnionitis was diag-
nosed by histological examination of the placenta.
Blood cell counts were analyzed every 2 weeks 
(± 7 days) and as needed.  Automated blood cell count-
ers (XE5000,  Sysmex,  Lincolnshire,  IL,  USA) were 
used to analyze white blood cell counts.  Eosinophils 
were counted by trained lab technicians.
Infants who fulfilled the criteria for LCC (Table 1) 
[11] were administered a physiological dose of hydro-
cortisone (1-2 mg/kg/dose).
The LCC group was composed of infants diagnosed 
with LCC and treated with steroids.  Infants who had 
not undergone steroid treatment were assigned to the 
control group.  The ‘pre-steroid eosinophil counts’ were 
evaluated using blood samples collected within 1 week 
before steroid administration in the LCC group.  The 
‘post-steroid eosinophil counts’ were evaluated using 
blood samples collected within 3-24 h after steroid 
administration.  We compared “the pre-steroid eosino-
phil counts and post-steroid eosinophil counts in the 
LCC group.  In the LCC group,  the eosinophil counts at 
LCC onset and those within 24 h after the first steroid 
treatment were used for the analysis,  whereas those at 
recurrence were excluded.  We also compared the high-
est eosinophil counts during hospitalization between the 
LCC and control groups.
To evaluate the characteristics of the infants,  we 
conducted a statistical analysis using the Chi-squared 
and Kruskal-Wallis tests (IBM SPSS® Statistics v.24).  To 
evaluate the eosinophil counts,  which are nonparamet-
ric data,  the statistical analysis was performed using the 
Mann-Whitney U-test.  The statistical significance level 
was set at p < 0.05.
Results
During the study period,  56 infants were included,  
of which 40 were administered steroid treatment at least 
once during their hospitalization; among these,  
18 infants were diagnosed with LCC.  Twelve infants 
whose eosinophil counts were measured before LCC 
(within 1 week before steroid treatment) and after ste-
roid treatment (3-24 h after steroid treatment) were 
classified as the LCC group.  A total of 16 patients who 
did not receive steroid treatment were classified as the 
control group (Fig. 1 and Table 2).  The time course of 
the eosinophil counts was evaluated using the median 
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Table 1　 Diagnostic criteria for late-onset circulatory collapse [11]
1. One week or longer since birth
2. No inotropic agent administered
3. Any of the following:
• Mean blood pressure ≤80% of that in the previous stable state or systolic blood pressure<40 mmHg
• Urine volume of ≤0.5 mL/kg/h over the past 8 h or ≤1.0 mL/kg/h over  the past 24 h
4. No other apparent cause of hypotension (cardiac failure,  dehydration,  patent ductus arteriosus,  or systemic infection)
counts of the infants in the control group at the post-
menstrual age to avoid the effects of steroid treatment 
(Fig. 2).  The eosinophil counts peaked at 30-31 weeks’ 
postmenstrual age.  Infants in the LCC group had sig-
nificantly lower gestational ages and birth weights com-
pared to those in the control group (Table 3).
We recorded the eosinophil counts both before and 
after steroid treatment in the 12 infants in the LCC 
group: the pre- and post-steroid median eosinophil 
counts were 0.877×109/L and 0.271×109/L,  respectively.  
The post-steroid eosinophil counts were significantly lower 
than the pre-steroid eosinophil counts (p=0.003,  Fig.3).
The highest eosinophil counts during hospitalization 
in the LCC group were compared with those in the con-
trol group to avoid steroid treatment effects (Table 3).  
The peak eosinophil counts were significantly higher in 
the LCC group than in the control group,  and the post-
menstrual age was significantly earlier in LCC group,  
which reflected the onset of LCC.
Discussion
This is the first study to identify a relationship 
between eosinophilia and LCC in preterm infants.  Our 
analyses revealed that the eosinophil counts were ele-
vated under conditions in which steroid treatment for 
LCC was required.  Earlier studies found that preterm 
infants are potentially in states of relative adrenal insuf-
ficiency due to reduced 3β-HSD activity,  thus placing 
them at risk for LCC [13 , 14].  Considering these find-
ings together with the proposal that eosinophilia may 
reflect adrenal insufficiency [17],  our results suggest 
that transient eosinophilia in preterm infants may be 
induced by relative adrenal insufficiency.
We observed that the eosinophil counts in the con-
trol group gradually increased after birth,  reached a 
peak at 30-31 weeks’ postmenstrual age,  and subse-
quently decreased.  The eosinophil counts reached a 
peak at 28 weeks in the LCC group.  These results are 
similar to those reported in investigations in which 
almost all of the infants recovered from eosinophilia 
[1 , 18 , 19].  LCC is likely to occur at 28-29 weeks’ gesta-
tion and peak at 2-4 weeks after birth [20],  consistent 
with the eosinophil count trends identified in the pres-
ent study.  More premature infants need steroid treat-
ment and have a higher peak eosinophil count.  It may 
therefore be possible to predict the onset of LCC by 
prospectively following the time course of eosinophils,  
which will facilitate early intervention to prevent 
periventricular leukomalacia.
The results of our present analyses demonstrated 
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16 infants in the control group40 infants administered steroid therapy 
18 infants diagnosed with LCC
56 infants born before 28 week’s gestation
12 infants in the LCC group
6 infants were excluded for 
insufficient blood samples
Fig.  1　 Patient selection flow chart.
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Fig.  3　 Patient eosinophil counts before and after steroid 
infusion in the LCC group.
that the infants’ eosinophil counts after steroid treat-
ment were lower than those before steroid treatment.  
Similar results have been reported [21].  Steroids are 
considered the most effective therapy for eosinophilia,  
and they suppress the production and lifespan of eosin-
ophils by inhibiting cytokines such as granulocyte- 
macrophage colony stimulating factor (GM-CSF),  
interleukin (IL)-3,  and IL-5 [22].  Our results suggest 
that similar responses may occur in preterm infants.  
Steroid treatments may reduce the eosinophil counts in 
preterm babies by inhibiting cytokine production or 
activity.
This study has several limitations.  First,  despite the 
retrospective nature of the study,  the sample size was 
small.  The subjects were extremely premature infants 
with LCC,  and it was thus inevitable that the sample 
size would be small based on the incidence ratio.  Due to 
the small sample size,  we did not perform a multivari-
ate analysis,  and we were thus unable to determine the 
role of other factors (e.g.,  severe immaturity) that may 
have contributed to the development of eosinophilia in 
the LCC group.  A future multicenter prospective study 
to further clarify the relationship between LCC and 
eosinophilia is being planned to address this limitation.  
A second limitation is that cytokines that affect eosino-
philia (such as IL-3 and GM-CSF) were not evaluated.  
The assessment of these cytokines is essential in subse-
quent studies to elucidate the pathogenesis.
Our findings revealed a relationship between eosin-
ophilia and LCC in preterm infants.  Both eosinophilia 
and LCC may be caused by relative adrenal insuffi-
ciency.  Therefore,  eosinophilia is potentially a symp-
tom of LCC.
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